Open-label trial on efficacy and security of treatment with gemcitabine and oral modulation with tegafur and levofolinic acid (GEMTG) in patients with advanced pancreatic cancer by Pericay Pijaume, Carles, Escudero Emperador, Pilar, Bastús Piulats, Román, Campos Cervera, Juan Manuel, Esquerdo Galiana, Gaspar, Gallén Castillo, Manuel, Alfaro Gamero, Jordi, Dotor Navarro, Emma, Pisa Gatell, Aleydis, Guasch Jordán, Inmaculada, Saigí Grau, Eugeni

Get full text